You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Comparative analysis of the phase III clinical trials of anti-PD1 monotherapy in head and neck squamous cell carcinoma patients (CheckMate 141 and KEYNOTE 040)

Article metrics

Article menu

Download PDFPDF

XML
Commentary
Comparative analysis of the phase III clinical trials of anti-PD1 monotherapy in head and neck squamous cell carcinoma patients (CheckMate 141 and KEYNOTE 040)

 

Online download statistics by month:

Online download statistics by month: December 2019 to February 2026

AbstractFullPdf
Dec 2019330
Jan 202016166
Feb 202052527
Mar 202063637
Apr 2020313110
May 2020777741
Jun 2020858540
Jul 2020474726
Aug 2020494954
Sep 2020575733
Oct 2020505036
Nov 2020626233
Dec 2020494921
Jan 2021595942
Feb 2021494930
Mar 2021595934
Apr 2021505031
May 2021525426
Jun 2021687035
Jul 2021525222
Aug 2021525233
Sep 2021585836
Oct 2021565640
Nov 2021353541
Dec 2021626424
Jan 2022626412
Feb 2022424521
Mar 2022475136
Apr 2022353520
May 2022373720
Jun 2022373711
Jul 2022383820
Aug 2022303017
Sep 2022282820
Oct 2022383813
Nov 2022555528
Dec 2022414121
Jan 2023444420
Feb 2023303113
Mar 2023313114
Apr 2023232310
May 2023252519
Jun 2023262613
Jul 2023282819
Aug 2023191914
Sep 2023252514
Oct 2023282819
Nov 2023393916
Dec 2023191920
Jan 2024212115
Feb 2024525220
Mar 2024353682
Apr 2024343430
May 2024292919
Jun 2024293018
Jul 2024525224
Aug 202422217
Sep 2024222217
Oct 2024323227
Nov 2024384016
Dec 2024282820
Jan 2025454514
Feb 2025484828
Mar 2025343627
Apr 2025333320
May 2025767738
Jun 2025404033
Jul 2025110
Sep 2025110
Dec 2025220
Jan 2026110
Feb 2026110
Total279628181593